Filing Details
- Accession Number:
- 0001209191-13-023693
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-05-02 16:56:40
- Reporting Period:
- 2013-05-01
- Filing Date:
- 2013-05-02
- Accepted Time:
- 2013-05-02 16:56:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1131096 | Athenahealth Inc | ATHN | Services-Business Services, Nec (7389) | 043387530 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1494174 | H. Daniel Orenstein | 311 Arsenal Street Watertown MA 02472 | Svp, Gc, And Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-05-01 | 750 | $30.64 | 32,740 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-05-01 | 750 | $26.91 | 33,490 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-05-01 | 1,500 | $95.78 | 31,990 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-05-01 | 750 | $0.00 | 750 | $30.64 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-05-01 | 750 | $0.00 | 750 | $26.91 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 6,750 | 2009-07-01 | 2018-07-01 | No | 4 | M | Direct |
| 1,750 | 2011-07-05 | 2020-08-02 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on February 28, 2013, in accordance with Rule 10b5-1.
- This price represents the weighted average of sales ranging from $95.65 to $96.00. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
